Galen Partners
Venture Capital and Private Equity PrincipalsConnecticut, United States11-50 Employees
Galen Partners is a healthcare-focused principal investment firm based in Stamford, Connecticut. The firm concentrates on opportunities in healthcare information technology and outsourcing, medical devices, and specialty pharmaceuticals, seeking to take a lead role in working with established revenue-generating healthcare companies and to provide strategic guidance alongside management teams. Active since 1990, Galen has supported a number of healthcare market leaders, including Dow Pharmaceutical Sciences, EduNeering, Encore Medical, Lumenos, MedAssets, Medicode, MiniMed, Ocular Sciences, and Pyxis. In 2020, the firm announced the acquisition of Evolve Treatment Centers.